Health Canada
Symbol of the Government of Canada
Drugs and Health Products

HOMEOPATHY

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

This monograph is intended to serve as a guide to industry for the preparation of Product Licence Applications (PLAs) and labels for natural health product market authorization. It is not intended to be a comprehensive review of the medicinal ingredients.

Notes

  • By submitting a PLA referencing this monograph, the applicant is attesting that the product will comply fully with the recommended conditions of use outlined in this monograph. The conditions of use include methods of preparations, source materials, doses, durations of use, combinations of medicinal ingredients, and risk statements.
  • Text in parentheses is additional optional information which can be included on the PLA and product label at the applicant's discretion.
  • The solidus (/) indicates that the terms and/or statements are synonymous. Either term or statement may be selected by the applicant.

Date

August 5, 2019

Proper name(s), Common name(s), Source material(s)

Notes

  • The proper name(s), common name(s) and source material(s) must be as per the homeopathic monograph referenced as the Standard or Grade (please refer to the specifications).
  • The medicinal ingredient(s) must be a permitted substance with a homeopathic monograph in one of the Natural and Non-Prescription Health Products Directorate (NNHPD) accepted homeopathic pharmacopoeias1,2,3,4,5.
  • Medicinal ingredients considered imponderables are not included within the scope of this monograph.

Route(s) of administration

The acceptable route(s) of administration must be acceptable as per the NNHPD Evidence for Homeopathic Medicines guidance document.

Dosage Form(s)

The acceptable pharmaceutical dosage forms include, but are not limited to those indicated in Table 1 below.

This monograph excludes foods or food-like dosage forms as indicated in the Compendium of Monographs Guidance Document.

Use(s) or Purpose(s)

Homeopathic preparation/remedy/medicine.

Dose(s)

Subpopulation(s)

As specified below.

Quantity(ies)

Table 1. Dosage forms and their recommended dose for each subpopulation
Dosage Form(s) Subpopulation(s) General dosing Maximum Acute Dosing (Optional)
Maximum Dosing Maximum Frequency

Globules (small pellets, pills) (Oral)

Adolescents 12-17 years and Adults 18 years and older

1 whole unit dose(tube or container)

1 time per day

10-20 granules, 2-3 times per day

Children 1-11 years*

Infants 0-11 months*

Granules (regular or large pellets)

Adolescents 12-17 years and Adults 18 years and older

3-5 granules

2-3 times per day

Every 15-60 minutes (not to exceed 12 times per day) or until improvement of symptoms. Then resume general dosing.

Children 1-11 years*

Infants 0-11 months*

Tablets

Adolescents 12-17 years and Adults 18 years and older

1-4 tablets

1-4 times per day

Every 15-60 minutes (not to exceed 12 times per day) or until improvement of symptoms. Then resume general dosing.

Children 6-11 years

1-3 tablets

1-4 times per day

Children 1-5 years*

½-3 tablets

1-3 times per day

Infants 0-11 months*

½-3 tablets

1-2 times per day

Oral Drops

Adolescents 12-17 years and Adults 18 years and older

10-30 drops

1-3 times per day

Every 15-60 minutes (not to exceed 12 times per day) or until improvement of symptoms. Then resume general dosing.

Children 6-11 years

5-15 drops

Children 1-5 years

5-10 drops

Infants 0-11 months

1-5 drops

Liquid(Oral drinkable vials)

Adolescents 12-17 years and Adults 18 years and older

1 ampoule

1-3 times per day

Not to exceed 3 times per day

Children 6-11 years

2/3 ampoule

Children 1-5 years

½ ampoule

Infants 0-11 months

1/3 ampoule

Oral solution (Unit dose)

Adolescents 12-17 years and Adults 18 years and older

Unit oral dose

1-3 times per day

Give one unit dose upon onset of symptoms. Repeat two more times at 15-minute intervals. Repeat process up to 9 times per day if symptoms reappear.

Children 1-11 years

Infants 0-11 months

Oral Syrup

Adolescents 12-17 years and Adults 18 years and older

1-2 tsp

Every 4 to 6 hours

N/A

Children 1-11 years

½-1 tsp

1-3 times per day

Infants 0-11 months

½ tsp

1-3 times per day

Cream or Ointment

Infants 0-11 months, Children 1-11 years, Adolescents 12-17 and Adults 18 years and older

Cover affected area

Use as needed

N/A

Nasal spray

Adolescents 12-17 years and Adults 18 years and older

1-2 sprays/ nostril

3-5 times per day

N/A

Children 1-11 years

1 spray/nostril

4 times per day

Infants 0-11 months

1 spray/nostril

4 times per day

Eye Drops

Adolescents 12-17 years and Adults 18 years and older

2-3 drops

3 times per day

1 drop in the affected eye every 15 minutes for a maximum of 3 hours.

Children 1-11 years

1-2 drops

3 times per day

Infants 0-11 months

1 drop

2 times per day

Ear Drops

Adolescents 12-17 years and Adults 18 years and older

1 complete vial

3 times per day

Every 15-60 minutes (not to exceed 12 times per day) or until improvement of symptoms. Then resume general dosage.

Children 1-11 years

3-4 drops

Infants 0-11 months

2-3 drops

Suppositories

Adolescents 12-17 years and Adults 18 years and older

1 suppository

1-4 times per day

Maximum 5 times per day

Children 6-11 years

1-3 times per day

Maximum 4 times per day

Children 1-5 years

1-2 times per day

Maximum 3 times per day

Infants 0-11 months

1-2 times per day

Maximum 2 times per day

*Dissolve dose in a small amount of water before administration to infants and children 0-5 years old.

Potency

The homeopathic potency of each medicinal ingredient must be at or above the minimum potency specified in the Natural Health Products Ingredients Database (NHPID).

Note

The minimum potencies indicated in the NHPID are generally based on the following unless specific safety concerns have been identified:

  • The OTC limit for HPUS
  • 4D for HAB
  • 12 CH for pharmacopoeia other than HPUS or HAB/GHP

Method(s) of preparation

The method(s) of preparation must be as per the homeopathic monograph referenced as the Standard or Grade (please refer to the specifications). It is also acceptable to use another method from an NNHPD accepted homeopathic pharmacopoeia not referenced as the Standard or Grade. In this case, the selected method of preparation must be appropriate for the medicinal ingredient.

Direction(s) for use

Use as directed by a health care practitioner/health care provider/health care professional/doctor/physician.

Duration(s) of Use

No statement required.

Risk Information

Caution(s) and warning(s)

  • Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
  • Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant or breastfeeding.
  • Ingredient specific risk statements when required by NHPID.

Contraindication(s)

No statement required.

Known adverse reaction(s)

No statement required.

Non-medicinal ingredients

Must be chosen from the current Natural Health Products Ingredients Database (NHPID) and must meet the limitations outlined in the database.

Storage conditions

No statement required.

Specifications

  • The finished product must comply with the requirements outlined in the current NNHPD Evidence for Homeopathic Medicines guidance document.
  • The finished product specifications must be established in accordance with the requirements described in the Natural and Non-prescription Health Products Directorate (NNHPD) Quality of Natural Health Products Guide.
  • The medicinal ingredient(s) must comply with the requirements outlined in the NHPID.
  • All medicinal ingredients of animal origin must be sterilized as per HPUS and HAB requirements or equivalent.
  • If the method of preparation includes the use of natural lactose for trituration, an Animal Tissue form for lactose must be submitted.

Standard or Grade

Must reference a homeopathic monograph in one of the most recent versions of NNHPD accepted homeopathic pharmacopoeias: HPUS1, HAB/GHP2, PhF3, Ph.Eur.4, EHP5.

1Homeopathic Pharmacopeia of the United States (HPUS)

2Homöopathisches ArzneiBuch (HAB) or German Homeopathic Pharmacopoeia (GHP)

3Pharmacopée française or French Pharmacopoeia (PhF)

4European Pharmacopoeia (Ph.Eur.)

5Encyclopedia of Homeopathic Pharmacopoeia (EHP)

References Cited

  • EHP 2002: Encyclopaedia of Homeopathic Pharmacopoeia, Volume 3. New Delhi (IN): Kuldeep Jain and B.Jain, 2002.
  • GHP 2008: German Homeopathic Pharmacopoeia, Volume 1.Stuttgart (DE): MedPharm, 2008. HAB 2003: Homöopathisches ArzneiBuch, Band 1. Stuttgart (DE): MedPharm, 2003.
  • HPUS 2004: Homeopathic Pharmacopeia of the United States, Revision Service. Pennsylvania (PA): Homeopathic Pharmacopoeia Convention of the United States, 2004.
  • Ph.Eur. 2011: European Pharmacopoeia, 7th edition. Strasbourg (FR): Directorate for the Quality of Medicines and HealthCare of the Council of Europe (EDQM), 2011.
  • PhF 2003: French Pharmacopoeia, 10th edition. Saint-Denis Cedex(FR) : French Agency for the Safety of Health Products , 2003.